Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,179
archived clinical trials in
Anxiety

Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms
Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms
Status: Enrolling
Updated:  12/16/2015
University of Miami
mi
from
Coral Gables, FL
Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms
Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms
Status: Enrolling
Updated: 12/16/2015
University of Miami
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders
Prospective Randomized Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders
Status: Enrolling
Updated:  12/28/2015
Carolina Partners in Mental HealthCare
mi
from
Raleigh, NC
Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders
Prospective Randomized Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders
Status: Enrolling
Updated: 12/28/2015
Carolina Partners in Mental HealthCare
mi
from
Raleigh, NC
Click here to add this to my saved trials
Depression Agency-Based Collaboration
Depression Agency-Based Collaborative (Depression ABC)
Status: Enrolling
Updated:  12/29/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Depression Agency-Based Collaboration
Depression Agency-Based Collaborative (Depression ABC)
Status: Enrolling
Updated: 12/29/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics
Status: Enrolling
Updated:  12/30/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics
Status: Enrolling
Updated: 12/30/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effects of Tai Chi Chuan on Psychobiological Indicators of Anxiety and Sleep Quality in Young Adults
Effects of Tai Chi Chuan on Psychobiological Indicators of Anxiety and Sleep Quality in Young Adults
Status: Enrolling
Updated:  1/6/2016
Appalachian State University
mi
from
Boone, NC
Effects of Tai Chi Chuan on Psychobiological Indicators of Anxiety and Sleep Quality in Young Adults
Effects of Tai Chi Chuan on Psychobiological Indicators of Anxiety and Sleep Quality in Young Adults
Status: Enrolling
Updated: 1/6/2016
Appalachian State University
mi
from
Boone, NC
Click here to add this to my saved trials
Sleep, Mood, and Behavior Study
Sleep, Mood, and Behavior Study:Transdisciplinary Studies of CBT for Anxiety in Youth
Status: Enrolling
Updated:  1/6/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Sleep, Mood, and Behavior Study
Sleep, Mood, and Behavior Study:Transdisciplinary Studies of CBT for Anxiety in Youth
Status: Enrolling
Updated: 1/6/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety
Personalizing Treatment of Depression Complicated by Panic Features-Pilot Study
Status: Enrolling
Updated:  1/7/2016
Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety
Personalizing Treatment of Depression Complicated by Panic Features-Pilot Study
Status: Enrolling
Updated: 1/7/2016
Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Health Promotion in Early Adolescence: Sleep, Activity, and Emotion Regulation
Health Promotion in Early Adolescence: Sleep, Activity, and Emotion Regulation
Status: Enrolling
Updated:  1/8/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Health Promotion in Early Adolescence: Sleep, Activity, and Emotion Regulation
Health Promotion in Early Adolescence: Sleep, Activity, and Emotion Regulation
Status: Enrolling
Updated: 1/8/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Calmer Life: Testing the Effectiveness of a Treatment for Anxiety
Calmer Life: A Randomized Controlled Trial of a Participant-Centered Treatment for Anxiety in Low-Income, Older Adults
Status: Enrolling
Updated:  1/11/2016
Houston Center for Quality of Care and Utilization Studies
mi
from
Houston, TX
Calmer Life: Testing the Effectiveness of a Treatment for Anxiety
Calmer Life: A Randomized Controlled Trial of a Participant-Centered Treatment for Anxiety in Low-Income, Older Adults
Status: Enrolling
Updated: 1/11/2016
Houston Center for Quality of Care and Utilization Studies
mi
from
Houston, TX
Click here to add this to my saved trials
Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair
Double Blinded Randomized Controlled Trial of Intranasal Dexmedetomidine Versus Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair in the Emergency Department
Status: Enrolling
Updated:  1/13/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair
Double Blinded Randomized Controlled Trial of Intranasal Dexmedetomidine Versus Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair in the Emergency Department
Status: Enrolling
Updated: 1/13/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Online Treatments for Mood and Anxiety Disorders in Primary Care
Online Treatments for Mood and Anxiety Disorders in Primary Care
Status: Enrolling
Updated:  1/19/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Online Treatments for Mood and Anxiety Disorders in Primary Care
Online Treatments for Mood and Anxiety Disorders in Primary Care
Status: Enrolling
Updated: 1/19/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Adjusting to Chronic Conditions Using Education, Support, and Skills
Cognitive Behavioral Therapy in Primary Care: Treating the Medically Ill
Status: Enrolling
Updated:  1/25/2016
VA Medical Center, Oklahoma City
mi
from
Oklahoma City, OK
Adjusting to Chronic Conditions Using Education, Support, and Skills
Cognitive Behavioral Therapy in Primary Care: Treating the Medically Ill
Status: Enrolling
Updated: 1/25/2016
VA Medical Center, Oklahoma City
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Adjusting to Chronic Conditions Using Education, Support, and Skills
Cognitive Behavioral Therapy in Primary Care: Treating the Medically Ill
Status: Enrolling
Updated:  1/25/2016
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Adjusting to Chronic Conditions Using Education, Support, and Skills
Cognitive Behavioral Therapy in Primary Care: Treating the Medically Ill
Status: Enrolling
Updated: 1/25/2016
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Click here to add this to my saved trials
CBT for Social Anxiety Disorder Delivered by School Counselors
CBT for Social Anxiety Disorder Delivered by School Counselors
Status: Enrolling
Updated:  1/28/2016
New York University School of Medicine
mi
from
New York, NY
CBT for Social Anxiety Disorder Delivered by School Counselors
CBT for Social Anxiety Disorder Delivered by School Counselors
Status: Enrolling
Updated: 1/28/2016
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
An Open-label Study Evaluating the Pharmacokinetics and Tolerability of [Vortioxetine] Lu AA21004 in Connection With Multiple Oral Dosing of [Vortioxetine] Lu AA21004 in Child and Adolescent Patients With a DSM-IV Diagnosis of Depressive or Anxiety Disorder
Status: Enrolling
Updated:  1/29/2016
US001
mi
from
Cleveland, OH
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
An Open-label Study Evaluating the Pharmacokinetics and Tolerability of [Vortioxetine] Lu AA21004 in Connection With Multiple Oral Dosing of [Vortioxetine] Lu AA21004 in Child and Adolescent Patients With a DSM-IV Diagnosis of Depressive or Anxiety Disorder
Status: Enrolling
Updated: 1/29/2016
US001
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
An Open-label Study Evaluating the Pharmacokinetics and Tolerability of [Vortioxetine] Lu AA21004 in Connection With Multiple Oral Dosing of [Vortioxetine] Lu AA21004 in Child and Adolescent Patients With a DSM-IV Diagnosis of Depressive or Anxiety Disorder
Status: Enrolling
Updated:  1/29/2016
US002
mi
from
Cincinnatti, OH
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
An Open-label Study Evaluating the Pharmacokinetics and Tolerability of [Vortioxetine] Lu AA21004 in Connection With Multiple Oral Dosing of [Vortioxetine] Lu AA21004 in Child and Adolescent Patients With a DSM-IV Diagnosis of Depressive or Anxiety Disorder
Status: Enrolling
Updated: 1/29/2016
US002
mi
from
Cincinnatti, OH
Click here to add this to my saved trials
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
An Open-label Study Evaluating the Pharmacokinetics and Tolerability of [Vortioxetine] Lu AA21004 in Connection With Multiple Oral Dosing of [Vortioxetine] Lu AA21004 in Child and Adolescent Patients With a DSM-IV Diagnosis of Depressive or Anxiety Disorder
Status: Enrolling
Updated:  1/29/2016
US003
mi
from
Washington,
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
An Open-label Study Evaluating the Pharmacokinetics and Tolerability of [Vortioxetine] Lu AA21004 in Connection With Multiple Oral Dosing of [Vortioxetine] Lu AA21004 in Child and Adolescent Patients With a DSM-IV Diagnosis of Depressive or Anxiety Disorder
Status: Enrolling
Updated: 1/29/2016
US003
mi
from
Washington,
Click here to add this to my saved trials
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
An Open-label Study Evaluating the Pharmacokinetics and Tolerability of [Vortioxetine] Lu AA21004 in Connection With Multiple Oral Dosing of [Vortioxetine] Lu AA21004 in Child and Adolescent Patients With a DSM-IV Diagnosis of Depressive or Anxiety Disorder
Status: Enrolling
Updated:  1/29/2016
US004
mi
from
Wichita, KA
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
An Open-label Study Evaluating the Pharmacokinetics and Tolerability of [Vortioxetine] Lu AA21004 in Connection With Multiple Oral Dosing of [Vortioxetine] Lu AA21004 in Child and Adolescent Patients With a DSM-IV Diagnosis of Depressive or Anxiety Disorder
Status: Enrolling
Updated: 1/29/2016
US004
mi
from
Wichita, KA
Click here to add this to my saved trials
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
An Open-label Study Evaluating the Pharmacokinetics and Tolerability of [Vortioxetine] Lu AA21004 in Connection With Multiple Oral Dosing of [Vortioxetine] Lu AA21004 in Child and Adolescent Patients With a DSM-IV Diagnosis of Depressive or Anxiety Disorder
Status: Enrolling
Updated:  1/29/2016
DE002
mi
from
Berlin,
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
An Open-label Study Evaluating the Pharmacokinetics and Tolerability of [Vortioxetine] Lu AA21004 in Connection With Multiple Oral Dosing of [Vortioxetine] Lu AA21004 in Child and Adolescent Patients With a DSM-IV Diagnosis of Depressive or Anxiety Disorder
Status: Enrolling
Updated: 1/29/2016
DE002
mi
from
Berlin,
Click here to add this to my saved trials
Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
Status: Enrolling
Updated:  1/29/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
Status: Enrolling
Updated: 1/29/2016
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
Status: Enrolling
Updated:  1/29/2016
Yuma Regional Medical Center
mi
from
Yuma, AZ
Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
Status: Enrolling
Updated: 1/29/2016
Yuma Regional Medical Center
mi
from
Yuma, AZ
Click here to add this to my saved trials
Web Based Therapist Training on Cognitive Behavior Therapy for Anxiety Disorders
Web Based Therapist Training on Cognitive Behavior Therapy for Anxiety Disorders
Status: Enrolling
Updated:  2/1/2016
Center for Telepsychology
mi
from
Madison, WI
Web Based Therapist Training on Cognitive Behavior Therapy for Anxiety Disorders
Web Based Therapist Training on Cognitive Behavior Therapy for Anxiety Disorders
Status: Enrolling
Updated: 2/1/2016
Center for Telepsychology
mi
from
Madison, WI
Click here to add this to my saved trials
Preoperative Anxiety Evaluation: a New Visual Smileys Scale
Preoperative Anxiety Evaluation: a New Visual Smileys Scale
Status: Enrolling
Updated:  2/2/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Preoperative Anxiety Evaluation: a New Visual Smileys Scale
Preoperative Anxiety Evaluation: a New Visual Smileys Scale
Status: Enrolling
Updated: 2/2/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hormonal Factors in the Treatment of Anorexia Nervosa
Hormonal Factors in the Treatment of Anorexia Nervosa
Status: Enrolling
Updated:  2/9/2016
Massachusetts General Hospital
mi
from
Boston, MA
Hormonal Factors in the Treatment of Anorexia Nervosa
Hormonal Factors in the Treatment of Anorexia Nervosa
Status: Enrolling
Updated: 2/9/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
Preventing Post-Operative Delirium in Pneumonectomy, Esophagectomy and Thoracotomy Patients
Status: Enrolling
Updated:  2/9/2016
University Hospital
mi
from
Indianapolis, IN
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
Preventing Post-Operative Delirium in Pneumonectomy, Esophagectomy and Thoracotomy Patients
Status: Enrolling
Updated: 2/9/2016
University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder
Hydroxyzine Effects on Meal-Related Anxiety in Underweight Adolescents and Young Adults Diagnosed With an Eating Disorder - A Pilot Study
Status: Enrolling
Updated:  2/17/2016
Melrose Institute
mi
from
Minneapolis, MN
Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder
Hydroxyzine Effects on Meal-Related Anxiety in Underweight Adolescents and Young Adults Diagnosed With an Eating Disorder - A Pilot Study
Status: Enrolling
Updated: 2/17/2016
Melrose Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Tuscon, AZ
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Tuscon, AZ
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Garden Grove, CA
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Oceanside, CA
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Temecula, CA
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Temecula, CA
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Gainesville, FL
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Miami, FL
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Atlanta, GA
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Lafayette, IN
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Lafayette, IN
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Baltimore, MD
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Boston, MA
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Haverhill, MA
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Haverhill, MA
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Rochester Hills, MI
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
New York, NY
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Staten Island, NY
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Salem, OR
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Salem, OR
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Allentown, PA
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Arlington, TX
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Austin, TX
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Woodstock, VT
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Woodstock, VT
Click here to add this to my saved trials
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Richmond, VA
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Protocol 331-13-002: An Exploratory, Multicenter, Open-label, Flexible-dose Trial of Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Randomized, Placebo-Controlled Study: Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Patients
A Randomized Prospective Placebo-Controlled Study of the Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Surgery Patients
Status: Enrolling
Updated:  2/29/2016
NYU Langone Medical Center
mi
from
New York, NY
Randomized, Placebo-Controlled Study: Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Patients
A Randomized Prospective Placebo-Controlled Study of the Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Surgery Patients
Status: Enrolling
Updated: 2/29/2016
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated:  3/8/2016
New York State Psychiatric Institute Anxiety Disorders Clinic
mi
from
New York, NY
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated: 3/8/2016
New York State Psychiatric Institute Anxiety Disorders Clinic
mi
from
New York, NY
Click here to add this to my saved trials
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated:  3/8/2016
Adult Anxiety Clinic of Temple University
mi
from
Philadelphia, PA
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated: 3/8/2016
Adult Anxiety Clinic of Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials